General contact

Main switchboard

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST


Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999


Investor Relations

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Data privacy

Data privacy

Everyone expects their personal information to remain confidential. This includes anything that can identify them—name, work and home address, family information, employment or financial details, or more sensitive health information. We strongly condemn the disclosure of any information that could lead to any form of discrimination, as well as the use of identifiable genetic data without informed consent.

We adhere to all privacy laws and enforce clear policies on protecting personal information, including genetic data. Our data privacy program includes a global organization and infrastructure as well as procedures and trainings to support local activities and ensure compliance, The Novartis Binding Corporate Rules are a system of principles, rules and tools to ensure effective levels of data protection, in particular relating to transfers of personal information outside Europe and Switzerland.